Finoriq research workspace
BioAge Labs, Inc. (BIOA) Company Overview
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates. Review BIOA filings, fundamentals, valuation, and ownership on Finoriq.
Company Snapshot
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
- Company
- BioAge Labs, Inc. (BIOA)
- Ticker
- BIOA
- Market Cap
- $999.7M
- Latest Price
- $22.49
- Industry
- Biotech & Pharma
BioAge Labs, Inc. (BIOA) Current Valuation Metrics
Static valuation preview for BioAge Labs, Inc. (BIOA). Market data retrieved 2026-07-08. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 102x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | -8.6% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -8.4% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 2.77x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.